Focal Bronchiectasis Causing Abnormal Pulmonary Radioiodine Uptake in a Patient with Well-Differentiated Papillary Thyroid Carcinoma

Background. False-positive pulmonary radioactive iodine uptake in the followup of differentiated thyroid carcinoma has been reported in patients with certain respiratory conditions. Patient Findings. We describe a case of well-differentiated papillary thyroid carcinoma treated by total thyroidectomy...

Full description

Bibliographic Details
Published in:	Case Reports in Endocrinology
Main Authors:	Ash Gargya, Elizabeth Chua
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Online Access:	http://dx.doi.org/10.1155/2012/452758

Similar Items

Hyponatremia and Cerebral Edema Associated with Radioiodine Therapy for Papillary Thyroid Carcinoma
by: Monica Therese C. Cabral, et al.
Published: (2014-05-01)

mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer
by: Ju Yeon Pyo, et al.
Published: (2024-11-01)

Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma
by: Pepijn van Houten, et al.
Published: (2024-08-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Metastases of papillary radioiodine-refractory thyroid cancer in the parapharyngeal lymph node: clinical case
by: N. A. Ognerubov, et al.
Published: (2021-04-01)

Added Value of Postoperative Radioiodine Scan for Staging and Risk Stratification in Papillary Thyroid Microcarcinoma
by: Tawika Kaewchur, et al.
Published: (2021-04-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
by: Enrique Cadena-Piñeros, et al.
Published: (2022-12-01)

Blood Profiles in the Prediction of Radioiodine Refractory Papillary Thyroid Cancer: A Case–Control Study
by: Liu H, et al.
Published: (2023-02-01)

Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
by: Qinglin Li, et al.
Published: (2023-01-01)

Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.
by: Peng Hou, et al.
Published: (2009-07-01)

The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes
by: Jingjia Cao, et al.
Published: (2023-12-01)

The Effects of Radioiodine Therapy on the Recovery of Parathyroid Function in Patients with Protracted Hypoparathyroidism after Total Thyroidectomy for Papillary Thyroid Carcinoma
by: Munire Abuduwaili, et al.
Published: (2022-11-01)

Phenotype and Clinicoradiological Differences in Multifocal and Focal Bronchiectasis
by: Jelena Jankovic, et al.
Published: (2024-05-01)

The influence of thionamides on intra-thyroidal uptake of 131I during radioiodine-131 treatment of Graves’ disease
by: Christian Happel, et al.
Published: (2023-12-01)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
by: Urbano Anido Herranz
Published: (2022-10-01)

Cystic Papillary Thyroid Carcinoma
by: Darwin Totesora, et al.
Published: (2019-11-01)

The effect of BRAFV600E mutation on radioiodine therapy in patients with papillary thyroid carcinoma: a meta-analysis and systematic review
by: Bin Wang, et al.
Published: (2025-09-01)

Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors
by: Tetiana Bogdanova, et al.
Published: (2024-01-01)

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
by: Meihua Jin, et al.
Published: (2020-09-01)

Systemic treatments for radioiodine-refractory thyroid cancers
by: Piaohong Chen, et al.
Published: (2024-10-01)

Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
by: Genpeng Li, et al.
Published: (2018-11-01)

High RPMB predicts poor disease-free survival of male N1 papillary thyroid cancer after adjuvant radioiodine therapy
by: Ning An, et al.
Published: (2022-11-01)

Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01)

Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Tracheal Obstruction by an Invading Well-Differentiated Thyroid Carcinoma
by: Nickolaos Pontikides, et al.
Published: (2013-01-01)

Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
by: J. Nwatsock, et al.
Published: (2012-01-01)

Progress and prospect on treatment for radioiodine-refractory thyroid cancer
by: GENG Qianqian, YANG Aimin
Published: (2025-01-01)

Performance tests of a portable thyroid radioiodine meter
by: Zeshu Li, et al.
Published: (2024-03-01)

Uptake and effect of radioiodine exposure on SKBR-3 cell lines
by: Miftah Irramah, et al.
Published: (2019-12-01)

A digital pathology model for predicting radioiodine-avid metastases on initial post-therapeutic 131I scan in patients with papillary thyroid cancer
by: Yuhang Xue, et al.
Published: (2024-11-01)

A practical approach on radioprotection in the treatment of radioiodine for thyroid cancer
by: Janaína Dutra Silvestre Mendes, et al.
Published: (2018-09-01)

Acute leukemia arising after radioiodine treatment for thyroid cancer
by: Marine Gilabert, et al.
Published: (2012-08-01)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
by: Massimiliano Pacilio, et al.
Published: (2022-07-01)

Progress on Targeted Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
by: TENG Lisong, et al.
Published: (2023-05-01)

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
by: Hsi-Chen Tsai, et al.
Published: (2022-01-01)

A rare cause of bronchiectasis
by: Carlos Martín de Vicente, et al.
Published: (2024-02-01)

Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy
by: Leo Hashimoto, et al.
Published: (2025-07-01)

Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
by: E. V. Borodavina, et al.
Published: (2024-12-01)

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases
by: Shenghong Zhang, et al.
Published: (2024-02-01)

Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer
by: S. K. Zyryanov, et al.
Published: (2018-05-01)